Asymptomatic often sent for lung cancer screening tests

March 13, 2012
Asymptomatic often sent for lung cancer screening tests

(HealthDay) -- A majority of primary care physicians report ordering lung cancer screening tests for asymptomatic patients, according to research published in the March/April issue of the Annals of Family Medicine.

Using questionnaires completed by 962 family physicians, general practitioners, and , Carrie N. Klabunde, Ph.D., of the in Bethesda, Md., and associates assessed primary care physicians' knowledge of guidelines, beliefs about screening, and ordering of tests. Intentions to screen asymptomatic 50-year-old patients with varying smoking histories for the disease were assessed by use of clinical vignettes.

The researchers found that, during 2006 to 2007, 38 percent ordered no lung cancer screening tests, and 55, 22, and less than 5 percent ordered chest radiographs, low-dose spiral computed tomography, and sputum cytology tests, respectively, for asymptomatic patients. In multivariate modeling, physicians who were more likely to have ordered these tests were those who believed that expert groups recommended screening or that screening was effective, those whose usual practice was to recommend screening for asymptomatic patients (including those without substantial smoking exposure), and those whose patients asked about screening.

"Our findings that a majority of reported ordering lung cancer screening tests for asymptomatic patients and that patients have recently asked them about lung cancer screening suggest that ordering of these tests is common among these physicians," the authors write. "At the time of the survey, lung cancer screening was not recommended by major expert groups in the United States."

Explore further: Study finds that annual screening with chest x-ray does not reduce rate of lung cancer deaths

More information: Abstract
Full Text

Related Stories

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.